At least 7,500 measles cases in US in 2026 priced at 28.5%

Measles contract moves higher

Polymarket’s contract on whether the U.S. will record at least 7,500 measles cases in 2026 was priced at 28.5%, up 7.5 percentage points, with $215K traded, according to the supplied market summary published Oct 17, 2026, at 7:24 PM ET.

The increase represents a higher market-implied probability for the threshold, though the price remains below 50%. The supplied material does not identify a public-health update or other event behind the move.

What the tracker establishes

According to predictionbubbles.net, the measles contract appeared among the highlighted movers on its board, which tracks Polymarket and Kalshi. The supplied page records a venue-data snapshot of 17 Oct 2026, 23:43 UTC, and says its figures refresh every 15 minutes.

The tracker ranks changes over 24 hours by their absolute size in probability points, rather than relative percentages. Its universe covered 2,022 markets with lifetimes longer than 14 days; only open contracts with a valid day-earlier comparison qualified for ranking.

That methodology separates price movement from trading activity: volume does not determine a contract’s position. The $215K traded provides context for the measles repricing, but the supplied material gives neither order-book depth nor current U.S. measles case totals.

What it means for prediction markets

• The signal is a repricing: The 7.5-point rise shows a change in traders’ assessment, not confirmation that the 7,500-case threshold will be reached.
• The underlying evidence is missing: Without case totals or an identified catalyst, the material cannot establish whether the move reflects new health data or trading dynamics.
• Settlement details matter: The supplied source does not specify the contract’s case-counting authority or resolution rules, limiting comparisons between its price and any eventual reported total.